4//SEC Filing
Lanman Richard B. 4
Accession 0001628280-19-013353
CIK 0001576280other
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 4:58 PM ET
Size
12.3 KB
Accession
0001628280-19-013353
Insider Transaction Report
Form 4
Lanman Richard B.
Chief Medical Officer
Transactions
- Exercise/Conversion
COMMON STOCK
2019-11-01$4.18/sh+2,305$9,635→ 84,320 total - Exercise/Conversion
COMMON STOCK
2019-11-01$8.80/sh+3,459$30,439→ 87,779 total - Sale
COMMON STOCK
2019-11-01$69.96/sh−5,764$403,249→ 82,015 total - Exercise/Conversion
STOCK OPTION (RIGHT TO BUY)
2019-11-01−3,459→ 39,196 totalExercise: $8.80Exp: 2028-08-21→ COMMON STOCK (3,459 underlying) - Exercise/Conversion
STOCK OPTION (RIGHT TO BUY)
2019-11-01−2,305→ 13,066 totalExercise: $4.18Exp: 2027-05-30→ COMMON STOCK (2,305 underlying)
Footnotes (4)
- [F1]These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The shares sold were acquired contemporaneously upon the cashless exercise of one or more stock options at an exercise price of $4.18 or $8.80 per share.
- [F2]The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $69.62 to $70.34. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F3]The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on April 1, 2017.
- [F4]The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on August 22, 2018.
Documents
Issuer
Guardant Health, Inc.
CIK 0001576280
Entity typeother
Related Parties
1- filerCIK 0001721003
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 4:58 PM ET
- Size
- 12.3 KB